[99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging

来自 EBSCO

阅读量:

62

摘要:

Demobesin 1 is a potent new GRP-R-selective bombesin (BN) analogue containing an open chain tetraamine chelator for stable technetium-99m binding. Following a convenient labelling protocol, the radiopeptide, [ 99m Tc]Demobesin 1, formed in nearly quantitative yields and with high specific activities. Both unlabelled and labelled peptide demonstrated high-affinity binding in membrane preparations of the human androgen-independent prostate adenocarcinoma PC-3 cell line. The IC 50 values determined for Demobesin 1 and [Tyr 4 ]BN were 0.70±0.08n M and 1.5±0.20n M , respectively, while the K d defined for [ 99m Tc/ 99g Tc]Demobesin 1 was 0.67±0.10n M . [ 99m Tc]Demobesin 1 was rather stable in murine plasma, whereas it degraded rapidly in kidney and liver homogenates. After injection in healthy Swiss albino mice, [ 99m Tc]Demobesin 1 accumulated very efficiently in the target organs (pancreas, intestinal tract) via a GRP-R-mediated process, as shown by in vivo receptor blocking experiments. An equally high and GRP-R-mediated uptake was exhibited by [ 99m Tc]Demobesin 1 after injection in PC-3 tumour-bearing athymic mice. The initial high radioligand uptake of 16.2±3.1%ID/g in the PC-3 xenografts at 1h p.i. remained at a similar level (15.61±1.19%ID/g) at 4h p.i. Even after 24h p.i., when the radioactivity had cleared from all other tissues, a value of 5.24±0.67%ID/g was still observed in the tumour. The high and prolonged localization of [ 99m Tc]Demobesin 1 at the tumour site and its rapid background clearance are very promising qualities for GRP-R-targeted tumour imaging in man.

展开

DOI:

10.1007/s00259-002-1040-x

被引量:

418

年份:

2003

通过文献互助平台发起求助,成功后即可免费获取论文全文。

我们已与文献出版商建立了直接购买合作。

你可以通过身份认证进行实名认证,认证成功后本次下载的费用将由您所在的图书馆支付

您可以直接购买此文献,1~5分钟即可下载全文,部分资源由于网络原因可能需要更长时间,请您耐心等待哦~

身份认证 全文购买

相似文献

参考文献

引证文献

辅助模式

0

引用

文献可以批量引用啦~
欢迎点我试用!

关于我们

百度学术集成海量学术资源,融合人工智能、深度学习、大数据分析等技术,为科研工作者提供全面快捷的学术服务。在这里我们保持学习的态度,不忘初心,砥砺前行。
了解更多>>

友情链接

百度云百度翻译

联系我们

合作与服务

期刊合作 图书馆合作 下载产品手册

©2025 Baidu 百度学术声明 使用百度前必读

引用